{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,25]],"date-time":"2026-07-25T04:03:43Z","timestamp":1784952223203,"version":"3.55.0"},"reference-count":58,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2022,5,9]],"date-time":"2022-05-09T00:00:00Z","timestamp":1652054400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2022,5,9]],"date-time":"2022-05-09T00:00:00Z","timestamp":1652054400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Neurochem Res"],"published-print":{"date-parts":[[2022,8]]},"DOI":"10.1007\/s11064-022-03600-5","type":"journal-article","created":{"date-parts":[[2022,5,9]],"date-time":"2022-05-09T08:11:21Z","timestamp":1652083881000},"page":"2211-2229","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["The Anti-Parkinson Potential of Gingko biloba-Supplement Mitigates Cortico-Cerebellar Degeneration and Neuropathobiological Alterations via Inflammatory and Apoptotic Mediators in Mice"],"prefix":"10.1007","volume":"47","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6654-2564","authenticated-orcid":false,"given":"Olusegun G.","family":"Adebayo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wadioni","family":"Aduema","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Modo U.","family":"Emmanuel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3569-3575","authenticated-orcid":false,"given":"Benneth","family":"Ben-Azu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Blessing O.","family":"Orji","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ekam","family":"Akpakpan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Oluwakemi Rachael","family":"Adebayo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ogechukwu G.","family":"Onuoha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6586-0421","authenticated-orcid":false,"given":"Abayomi M.","family":"Ajayi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,5,9]]},"reference":[{"key":"3600_CR1","doi-asserted-by":"publisher","first-page":"845","DOI":"10.1080\/15548627.2017.1390636","volume":"14","author":"J Liu","year":"2018","unstructured":"Liu J, Liu W, Lu Y et al (2018) Piperlongumine restores the balance of autophagy and apoptosis by increasing BCL2 phosphorylation in rotenone-induced Parkinson disease models. Autophagy 14:845\u2013861","journal-title":"Autophagy"},{"key":"3600_CR2","doi-asserted-by":"publisher","first-page":"30","DOI":"10.12965\/jer.1734906.453","volume":"13","author":"MS Shin","year":"2017","unstructured":"Shin MS, Kim TW, Lee JM et al (2017) Treadmill exercise alleviates nigrostriatal dopaminergic loss of neurons and fibers in rotenone-induced Parkinson rats. J Exerc Rehabilitat 13:30","journal-title":"J Exerc Rehabilitat"},{"key":"3600_CR3","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1016\/j.neuro.2020.11.005","volume":"82","author":"LA Fonseca-Fonseca","year":"2021","unstructured":"Fonseca-Fonseca LA, da Silva VD, Wong-Guerra M et al (2021) JM-20 protects against 6-hydroxydopamine-induced neurotoxicity in models of Parkinson\u2019s disease: mitochondrial protection and antioxidant properties. Neurotoxicology 82:89\u201398","journal-title":"Neurotoxicology"},{"key":"3600_CR4","doi-asserted-by":"publisher","first-page":"583","DOI":"10.1016\/j.ncl.2009.04.004","volume":"27","author":"AH Schapira","year":"2009","unstructured":"Schapira AH (2009) Etiology and pathogenesis of Parkinson disease. Neurol Clin 27:583\u2013603","journal-title":"Neurol Clin"},{"key":"3600_CR5","doi-asserted-by":"publisher","first-page":"5981","DOI":"10.1111\/febs.12335","volume":"280","author":"PM Antony","year":"2013","unstructured":"Antony PM, Diederich NJ, Kruger R et al (2013) The hallmarks of Parkinson\u2019s disease. FEBS J 280:5981\u20135993. https:\/\/doi.org\/10.1111\/febs.12335","journal-title":"FEBS J"},{"key":"3600_CR6","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1016\/j.tig.2015.01.004","volume":"31","author":"A Verstraeten","year":"2015","unstructured":"Verstraeten A, Theuns J, Van Broeckhoven C (2015) Progress in unraveling the genetic etiology of Parkinson disease in a genomic era. Trends Genet 31:140\u2013149","journal-title":"Trends Genet"},{"key":"3600_CR7","doi-asserted-by":"publisher","first-page":"384","DOI":"10.1212\/01.wnl.0000247740.47667.03","volume":"68","author":"ER Dorsey","year":"2007","unstructured":"Dorsey ER, Constantinescu R, Thompson JP et al (2007) Projected number of people with Parkinson disease in the most populous nations, 2005 through 2030. Neurology 68:384\u2013386","journal-title":"Neurology"},{"key":"3600_CR8","doi-asserted-by":"publisher","first-page":"537","DOI":"10.1002\/mds.27277","volume":"33","author":"R Savica","year":"2018","unstructured":"Savica R, Grossardt BR, Rocca WA et al (2018) Parkinson disease with and without Dementia: a prevalence study and future projections. Mov Disord 33:537\u2013543","journal-title":"Mov Disord"},{"key":"3600_CR9","doi-asserted-by":"publisher","first-page":"901","DOI":"10.1021\/acschemneuro.7b00468","volume":"9","author":"EL Gill","year":"2018","unstructured":"Gill EL, Raman S, Yost RA et al (2018) L-Carnitine inhibits lipopolysaccharide-induced nitric oxide production of SIM-A9 microglia cells. ACS Chem Neurosci 9:901\u2013905","journal-title":"ACS Chem Neurosci"},{"key":"3600_CR10","doi-asserted-by":"publisher","first-page":"785","DOI":"10.1002\/med.21714","volume":"41","author":"C Bento-Pereira","year":"2021","unstructured":"Bento-Pereira C, Dinkova-Kostova AT (2021) Activation of transcription factor Nrf2 to counteract mitochondrial dysfunction in Parkinson\u2019s disease. Med Res Rev 41:785\u2013802","journal-title":"Med Res Rev"},{"key":"3600_CR11","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1016\/j.celrep.2019.03.012","volume":"27","author":"S Lohani","year":"2019","unstructured":"Lohani S, Martig AK, Deisseroth K et al (2019) Dopamine modulation of prefrontal cortex activity is manifold and operates at multiple temporal and spatial scales. Cell Rep 27:99\u2013114","journal-title":"Cell Rep"},{"key":"3600_CR12","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1016\/j.parkreldis.2020.09.005","volume":"80","author":"K Kawabata","year":"2020","unstructured":"Kawabata K, Watanabe H, Bagarinao E et al (2020) Cerebello-basal ganglia connectivity fingerprints related to motor\/cognitive performance in Parkinson\u2019s disease. Parkinsonism Relat Disord 80:21\u201327","journal-title":"Parkinsonism Relat Disord"},{"key":"3600_CR13","doi-asserted-by":"publisher","first-page":"2019","DOI":"10.1002\/mds.28214","volume":"35","author":"S Stuart","year":"2019","unstructured":"Stuart S, Morris R, Giritharan A et al (2019) Prefrontal cortex activity and gait in Parkinson\u2019s disease with cholinergic and dopaminergic therapy. Mov Disord 35:2019\u20132027","journal-title":"Mov Disord"},{"key":"3600_CR14","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1016\/j.neuroscience.2021.02.019","volume":"460","author":"HR Tucker","year":"2021","unstructured":"Tucker HR, Mahoney E, Akhtar K et al (2021) Motor thalamic deep brain stimulation alters cortical activity and shows therapeutic utility for treatment of Parkinson\u2019s disease symptoms in a rat model. Neuroscience 460:88\u2013106","journal-title":"Neuroscience"},{"key":"3600_CR15","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1016\/j.tics.2018.12.006","volume":"23","author":"T Ott","year":"2019","unstructured":"Ott T, Nieder A (2019) Dopamine and cognitive control in prefrontal cortex. Trends Cogn Sci 23:213\u2013234","journal-title":"Trends Cogn Sci"},{"key":"3600_CR16","doi-asserted-by":"publisher","first-page":"589","DOI":"10.1177\/1545968320924430","volume":"34","author":"D Orcioli-Silva","year":"2020","unstructured":"Orcioli-Silva D, Vit\u00f3rio R, N\u00f3brega-Sousa P et al (2020) Levodopa facilitates prefrontal cortex activation during dual task walking in Parkinson disease. Neurorehabil Neural Repair 34:589\u2013599","journal-title":"Neurorehabil Neural Repair"},{"key":"3600_CR17","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3389\/fnhum.2015.00214","volume":"9","author":"SB Festini","year":"2015","unstructured":"Festini SB, Bernard JA, Kwak Y et al (2015) Altered cerebellar connectivity in Parkinson\u2019s patients ON and OFF L-DOPA medication. Front Hum Neurosci 9:1\u201313","journal-title":"Front Hum Neurosci"},{"key":"3600_CR18","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0000000000008754","author":"B Maiti","year":"2020","unstructured":"Maiti B, Koller JM, Snyder AZ (2020) Cognitive correlates of cerebellar Resting-state functional connectivity in Parkinson disease. Neurology. https:\/\/doi.org\/10.1212\/WNL.0000000000008754","journal-title":"Neurology"},{"key":"3600_CR19","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1016\/j.newideapsych.2004.09.002","volume":"22","author":"MJ Hogan","year":"2004","unstructured":"Hogan MJ (2004) The cerebellum in thought and action: a fronto-cerebellar aging hypothesis. New Ideas Psychol 22:97\u2013125","journal-title":"New Ideas Psychol"},{"key":"3600_CR20","doi-asserted-by":"publisher","first-page":"e95861","DOI":"10.1371\/journal.pone.0095861","volume":"9","author":"A van der Hoorn","year":"2014","unstructured":"van der Hoorn A, Renken RJ, Leenders KL et al (2014) Parkinson-related changes of activation in visuomotor brain regions during perceived forward self-motion. PLoS One 9:e95861","journal-title":"PLoS One"},{"key":"3600_CR21","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1016\/j.neuroscience.2021.08.021","volume":"475","author":"TJ Bosch","year":"2021","unstructured":"Bosch TJ, Groth C, Eldridge TA et al (2021) Altered cerebellar oscillations in Parkinson\u2019s disease patients during cognitive and motor tasks. Neuroscience 475:185\u2013196","journal-title":"Neuroscience"},{"key":"3600_CR22","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1016\/S1474-4422(06)70373-8","volume":"5","author":"KR Chaudhuri","year":"2006","unstructured":"Chaudhuri KR, Healy DG, Schapira AH (2006) National Institute for Clinical E. Non-motor symptoms of Parkinson\u2019s disease: diagnosis and management. Lancet Neurol 5:235\u2013245","journal-title":"Lancet Neurol"},{"key":"3600_CR23","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1186\/s40169-017-0181-2","volume":"7","author":"RR Ramsay","year":"2018","unstructured":"Ramsay RR, Popovic-Nikolic MR, Nikolic K et al (2018) A perspective on multi-target drug discovery and design for complex diseases. Clin Transl Med 7:3. https:\/\/doi.org\/10.1186\/s40169-017-0181-2","journal-title":"Clin Transl Med"},{"key":"3600_CR24","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1111\/j.1460-9568.2008.06314.x","volume":"28","author":"P Rojas","year":"2008","unstructured":"Rojas P, Serrano-Garcia N, Mares-Samano JJ et al (2008) EGb761 protects against nigrostriatal dopaminergic neurotoxicity in 1-methyl-4-phenyl-1,2,3, 6-tetrahydropyridine-induced Parkinsonism in mice: role of oxidative stress. Eur J Neurosci 28:141\u2013150","journal-title":"Eur J Neurosci"},{"key":"3600_CR25","doi-asserted-by":"publisher","first-page":"1259","DOI":"10.2174\/1389201021666200320135849","volume":"21","author":"NA Mohammed","year":"2020","unstructured":"Mohammed NA, Abdou HM, Tass MA et al (2020) Oral supplements of Ginkgo biloba extract alleviate neuroinflammation, oxidative impairments and neurotoxicity in rotenone-induced Parkinsonian rats. Curr Pharm Biotechnol 21:1259\u20131268","journal-title":"Curr Pharm Biotechnol"},{"key":"3600_CR26","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1016\/j.pathophys.2016.03.002","volume":"23","author":"N Sharma","year":"2016","unstructured":"Sharma N, Jamwal S, Kumar P (2016) Beneficial effect of antidepressants against rotenone induced Parkinsonism like symptoms in rats. Pathophysiology 23:123\u2013134","journal-title":"Pathophysiology"},{"key":"3600_CR27","first-page":"1","volume":"9","author":"OG Adebayo","year":"2021","unstructured":"Adebayo OG, Ben-Azu B, Ajayi AM et al (2021) Gingko biloba abrogate lead-induced neurodegeneration in mice hippocampus: involvement of NF-\u03baB expression, myeloperoxidase activity and pro-inflammatory mediators. Biol Trace Elem Res 9:1\u20134","journal-title":"Biol Trace Elem Res"},{"key":"3600_CR28","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1016\/j.lfs.2015.04.007","volume":"132","author":"AT Eduviere","year":"2015","unstructured":"Eduviere AT, Umukoro S, Aderibigbe AO et al (2015) Methyljasmonate enhances memory performance through inhibition of oxidative stress and acetylcholinesterase activity in mice. Life Sci 132:20\u201326","journal-title":"Life Sci"},{"key":"3600_CR29","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1016\/0165-0270(91)90048-5","volume":"36","author":"CP Montoya","year":"1991","unstructured":"Montoya CP, Campbell-Hope LJ, Pemberton KD et al (1991) The \u201cstaircase test\u201d: a measure of independent forelimb reaching and grasping abilities in rats. J Neurosci Methods 36:219\u2013228. https:\/\/doi.org\/10.1016\/0165-0270(91)90048-5","journal-title":"J Neurosci Methods"},{"key":"3600_CR30","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/j.jep.2018.07.019","volume":"226","author":"FTG Dereli","year":"2018","unstructured":"Dereli FTG, Ilhan M, Akkol EK (2018) Discovery of new antidepressant agents: In vivo study on Anthemis wiedemanniana Fisch. & Mey. J Ethnopharmacol 226:11\u201316","journal-title":"J Ethnopharmacol"},{"key":"3600_CR31","doi-asserted-by":"publisher","first-page":"25","DOI":"10.5214\/ans.0972.7531.260106","volume":"26","author":"RK Ruhela","year":"2019","unstructured":"Ruhela RK, Soni S, Sarma P et al (2019) Negative geotaxis: an early age behavioral hallmark to VPA rat model of autism. Ann Neurosci 26:25\u201331. https:\/\/doi.org\/10.5214\/ans.0972.7531.260106","journal-title":"Ann Neurosci"},{"key":"3600_CR32","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1016\/0003-2697(76)90527-3","volume":"72","author":"M Bradford","year":"1976","unstructured":"Bradford M (1976) A rapid and sensitive method for quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 72:248\u2013252","journal-title":"Anal Biochem"},{"key":"3600_CR33","doi-asserted-by":"publisher","first-page":"733","DOI":"10.1080\/09553009014552121","volume":"58","author":"R Varshney","year":"1990","unstructured":"Varshney R, Kale R (1990) Effect of calmodulin antagonists on radiation induced lipid peroxidation in microsomes. Int J Radiat Biol 58:733\u2013743","journal-title":"Int J Radiat Biol"},{"key":"3600_CR34","doi-asserted-by":"publisher","first-page":"2445","DOI":"10.1007\/s11011-021-00855-9","volume":"36","author":"SA Onasanwo","year":"2021","unstructured":"Onasanwo SA, Adamaigbo VO, Adebayo OG et al (2021) Moringa oleifera-supplemented diet protect against cortico-hippocampal neuronal degeneration in scopolamine-induced spatial memory deficit in mice: role of oxido-inflammatory and cholinergic neurotransmission pathway. Metab Brain Dis 36:2445\u20132460","journal-title":"Metab Brain Dis"},{"key":"3600_CR35","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1016\/0003-2697(82)90118-X","volume":"126","author":"LC Green","year":"1982","unstructured":"Green LC, Wagner DA, Glogowski J et al (1982) Analysis of nitrate, nitrite, and [15N] nitrate in biological fluids. Anal Biochem 126:131\u2013138","journal-title":"Anal Biochem"},{"key":"3600_CR36","volume-title":"Catalase activity","author":"A Clairborne","year":"1995","unstructured":"Clairborne A (1995) Catalase activity. CRC Press, Florida, Handbook of Methods for Oxygen Radical Research"},{"key":"3600_CR37","doi-asserted-by":"publisher","first-page":"7130","DOI":"10.1016\/S0021-9258(19)42083-8","volume":"249","author":"WH Habig","year":"1974","unstructured":"Habig WH, Pabst MJ, Jakoby WB (1974) Glutathione S-transferases. The first enzymatic step in mercapturic acid formation. J Biol Chem 249:7130\u20137139","journal-title":"J Biol Chem"},{"key":"3600_CR38","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1159\/000136485","volume":"11","author":"D Jollow","year":"1974","unstructured":"Jollow D, Mitchell J, Zampaglione N et al (1974) Bromobenzene induced liver necrosis: protective role of glutathione and evidence for 3, 4 bromobenzene oxide as the hepatotoxic metabolite. Pharmacology 11:151\u2013169","journal-title":"Pharmacology"},{"key":"3600_CR39","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1016\/0006-2952(61)90145-9","volume":"1","author":"GL Ellman","year":"1961","unstructured":"Ellman GL, Courtney KD, Andres V Jr et al (1961) A new and rapid colorimetric determination of acetylcholinesterase activity. Biochem Pharmacol 1:88\u201395","journal-title":"Biochem Pharmacol"},{"issue":"7","key":"3600_CR40","doi-asserted-by":"publisher","first-page":"e06378","DOI":"10.1016\/j.heliyon.2021.e06378","volume":"1","author":"I Wopara","year":"2021","unstructured":"Wopara I, Modo EU, Adebayo OG et al (2021) Anxiogenic and memory impairment effect of food color exposure: upregulation of oxido-neuroinflammatory markers and acetyl-cholinestrase activity in the prefrontal cortex and hippocampus. Heliyon 1(7):e06378","journal-title":"Heliyon"},{"key":"3600_CR41","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1111\/1523-1747.ep12506462","volume":"78","author":"PP Bradley","year":"1982","unstructured":"Bradley PP, Priebat DA, Christensen RD et al (1982) Measurement of cutaneous inflammation: estimation of neutrophil content with an enzyme marker. J Invest Dermatol 78:206\u2013209","journal-title":"J Invest Dermatol"},{"key":"3600_CR42","doi-asserted-by":"crossref","first-page":"1","DOI":"10.14440\/jbm.2014.36","volume":"7","author":"AD Edelstein","year":"2014","unstructured":"Edelstein AD, Tsuchida MA, Amodaj N et al (2014) Advanced methods of microscope control using \u03bcManager software. J Biol Methods 7:1","journal-title":"J Biol Methods"},{"key":"3600_CR43","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1016\/S0304-3940(99)00973-8","volume":"279","author":"A Wu","year":"2000","unstructured":"Wu A, Liu Y (2000) Apoptotic cell death in rat brain following deltamethrin treatment. Neurosci Lett 279:85\u201388","journal-title":"Neurosci Lett"},{"key":"3600_CR44","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1016\/0165-0270(95)00160-3","volume":"66","author":"E Angulo","year":"1996","unstructured":"Angulo E, Fernandez JA, Merchan M et al (1996) A reliable method for Golgi staining of retina and brain slices. J Neurosci Methods 66:55\u201359","journal-title":"J Neurosci Methods"},{"key":"3600_CR45","doi-asserted-by":"publisher","first-page":"261","DOI":"10.2165\/00003088-200241040-00003","volume":"41","author":"D Deleu","year":"2002","unstructured":"Deleu D, Northway MG, Hanssens Y (2002) Clinical pharmacokinetic and pharmacodynamic properties of drugs used in the treatment of Parkinson\u2019s disease. Clin Pharmacokinet 41:261\u2013309","journal-title":"Clin Pharmacokinet"},{"key":"3600_CR46","doi-asserted-by":"publisher","first-page":"3225","DOI":"10.1007\/s00213-020-05605-w","volume":"237","author":"EO Farombi","year":"2020","unstructured":"Farombi EO, Awogbindin IO, Olorunkalu PD et al (2020) Kolaviron protects against nigrostriatal degeneration and gut oxidative damage in a stereotaxic rotenone model of Parkinson\u2019s disease. Psychopharmacology 237:3225\u20133236","journal-title":"Psychopharmacology"},{"key":"3600_CR47","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.neuro.2021.02.002","volume":"84","author":"XL Zhang","year":"2021","unstructured":"Zhang XL, Huang WM, Tang PC et al (2021) Anti-inflammatory and neuroprotective effects of natural cordycepin in rotenone-induced PD models through inhibiting Drp1-mediated mitochondrial fission. Neurotoxicology 84:1\u20133","journal-title":"Neurotoxicology"},{"key":"3600_CR48","doi-asserted-by":"publisher","first-page":"1","DOI":"10.9734\/ajrb\/2021\/v8i230175","volume":"23","author":"IM Hassan","year":"2021","unstructured":"Hassan IM, Abdullahi AM (2021) Recent studies on the therapeutic and prophylactic effect of some agents on experimental induced Parkinson disease models review. Asian J Res Biochem 23:1\u20138","journal-title":"Asian J Res Biochem"},{"key":"3600_CR49","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1017\/cjn.2017.268","volume":"45","author":"S Kuang","year":"2018","unstructured":"Kuang S, Yang L, Rao Z et al (2018) Effects of Ginkgo biloba extract on A53T \u03b1-synuclein transgenic mouse models of Parkinson\u2019s disease. Can J Neurol Sci 45:182\u2013187","journal-title":"Can J Neurol Sci"},{"key":"3600_CR50","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1016\/j.jpha.2020.06.002","volume":"1","author":"D Yu","year":"2021","unstructured":"Yu D, Zhang P, Li J et al (2021) Neuroprotective effects of Ginkgo biloba dropping pills in Parkinson\u2019s disease. J Pharm Anal 1:220\u2013231","journal-title":"J Pharm Anal"},{"key":"3600_CR51","doi-asserted-by":"publisher","first-page":"e70951","DOI":"10.1371\/journal.pone.0070951","volume":"8","author":"D Hernandez-Baltazar","year":"2013","unstructured":"Hernandez-Baltazar D, Mendoza-Garrido ME, Martinez-Fong D (2013) Activation of GSK-3\u03b2 and caspase-3 occurs in nigral dopamine neurons during the development of apoptosis activated by a striatal injection of 6-hydroxydopamine. PloS one 8:e70951","journal-title":"PloS one"},{"key":"3600_CR52","doi-asserted-by":"publisher","first-page":"1381","DOI":"10.3892\/mmr.2015.4657","volume":"13","author":"Q Cui","year":"2016","unstructured":"Cui Q, Li X, Zhu H (2016) Curcumin ameliorates dopaminergic neuronal oxidative damage via activation of the Akt\/Nrf2 pathway. Mol Med Rep 13:1381\u20131388","journal-title":"Mol Med Rep"},{"key":"3600_CR53","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1016\/j.neuint.2017.11.006","volume":"112","author":"JA Lee","year":"2018","unstructured":"Lee JA, Son HJ, Choi JW et al (2018) Activation of the Nrf2 signaling pathway and neuroprotection of nigral dopaminergic neurons by a novel synthetic compound KMS99220. Neurochem Int 112:96\u2013107","journal-title":"Neurochem Int"},{"key":"3600_CR54","doi-asserted-by":"publisher","first-page":"1742","DOI":"10.1002\/tox.23295","volume":"36","author":"XD Zhou","year":"2021","unstructured":"Zhou XD, Wang JL, Guo DD et al (2021) Neuroprotective effect of targeted regulatory Nrf2 gene on rats with acute brain injury induced by carbon monoxide poisoning. Environ Toxicol 36:1742\u20131757","journal-title":"Environ Toxicol"},{"issue":"12","key":"3600_CR55","doi-asserted-by":"publisher","first-page":"342","DOI":"10.3389\/fnins.2018.00342","volume":"23","author":"S Franco-Iborra","year":"2018","unstructured":"Franco-Iborra S, Vila M, Perier C (2018) Mitochondrial quality control in neurodegenerative diseases: focus on Parkinson\u2019s disease and Huntington\u2019s disease. Front Neurosci 23(12):342","journal-title":"Front Neurosci"},{"key":"3600_CR56","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1016\/j.pbb.2016.09.002","volume":"150","author":"DK Khatri","year":"2016","unstructured":"Khatri DK, Juvekar AR (2016) Neuroprotective effect of curcumin as evinced by abrogation of rotenone-induced motor deficits, oxidative and mitochondrial dysfunctions in mouse model of Parkinson\u2019s disease. Pharmacol Biochem Behav 150:39\u201347","journal-title":"Pharmacol Biochem Behav"},{"key":"3600_CR57","doi-asserted-by":"publisher","first-page":"308","DOI":"10.1016\/j.jns.2017.08.3251","volume":"381","author":"K Kaur","year":"2017","unstructured":"Kaur K, Gill JS, Bansal PK et al (2017) Neuroinflammation - A major cause for striatal dopaminergic degeneration in Parkinson\u2019s Disease. J Neurol Sci 381:308\u2013314. https:\/\/doi.org\/10.1016\/j.jns.2017.08.3251","journal-title":"J Neurol Sci"},{"key":"3600_CR58","doi-asserted-by":"publisher","first-page":"5499","DOI":"10.2147\/DDDT.S90616","volume":"9","author":"S Ojha","year":"2015","unstructured":"Ojha S, Javed H, Azimullah S et al (2015) Neuroprotective potential of ferulic acid in the rotenone model of Parkinson\u2019s disease. Drug Des Dev Ther 9:5499\u20135510. https:\/\/doi.org\/10.2147\/DDDT.S90616","journal-title":"Drug Des Dev Ther"}],"container-title":["Neurochemical Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11064-022-03600-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11064-022-03600-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11064-022-03600-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,9,24]],"date-time":"2024-09-24T03:29:18Z","timestamp":1727148558000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11064-022-03600-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,5,9]]},"references-count":58,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2022,8]]}},"alternative-id":["3600"],"URL":"https:\/\/doi.org\/10.1007\/s11064-022-03600-5","relation":{},"ISSN":["0364-3190","1573-6903"],"issn-type":[{"value":"0364-3190","type":"print"},{"value":"1573-6903","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,5,9]]},"assertion":[{"value":"4 February 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 March 2022","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 April 2022","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 May 2022","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"The experiment was done within the PAMO University of Medical Sciences Animal Research Ethics Committee (PUMS-AREC\/App\/03\/0103\/03) which adheres to the \u201cGuide to the care and use of laboratory animals in research and teaching\u201d as prescribed in NIH publications volume 25 No.28 revised in 1996.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical Approval"}}]}}